In short, CircleDNA utilises Whole Exome Sequencing technology, powered by Illumina Novaseq 6000 Systems – the most advanced DNA technology when it comes to consumer DNA testing. Typically, WES technology is used for clinical grade DNA testing which is performed at hospitals, private clinics, and academic institutions which can range from USD $2,000-5,000 per test. We believe, though, this technology should be democratised and accessible to all, which is one of the main reasons we created Circle. Other consumer DNA tests use a technology called genotyping which looks at only SNPs of your gene. Genotyping is significantly less costly and more importantly, it is much less accurate. As an example, 23andMe utilises genotyping technology and in order to screen for Breast Cancer, they look at only 3 variants associated with BRCA 1/2 – an approach that has resulted in published studies of over 90% false positive results. With CircleDNA and our WES technology, we look at over 5,791 known variants associated with Breast Cancer and BRCA 1/2. In summary, with WES technology, you get much more comprehensive and accurate results.